Literature DB >> 16339514

Cutting edge: FADD is not required for antigen receptor-mediated NF-kappaB activation.

Adrian F Arechiga1, Bryan D Bell, Jennifer C Solomon, Isaac H Chu, Claire L Dubois, Brian E Hall, Thaddeus C George, David M Coder, Craig M Walsh.   

Abstract

Recently, it has been demonstrated that stimulated T cells bearing defects in caspase-8 fail to promote nuclear shuttling of NF-kappaB complexes. Such cells display strikingly similar proliferative and survival defects as T cells lacking Fas-associated death domain protein (FADD) function. We characterized NF-kappaB signaling in T cells bearing a dominant-negative FADD transgene (FADDdd). Whereas FADDdd T cells displayed proliferative defects following activation, these were not a consequence of aberrant NF-kappaB signaling, as measured by IKK/IkappaB phosphorylation and IkappaB degradation. There were no appreciable defects in nuclear translocation of p65/Rel using ImageStream, a flow-based imaging cytometer. Pretreatment with benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone, a potent caspase inhibitor, also failed to impede canonical NF-kappaB signaling. Secretion of IL-2 and up-regulation of various activation markers occurred normally. Thus, FADD does not play an essential role in NF-kappaB activation, suggesting an alternative route by which this adaptor promotes the clonal expansion of T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339514     DOI: 10.4049/jimmunol.175.12.7800

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.

Authors:  Hongbo Wang; Bartosz Grzywacz; David Sukovich; Valarie McCullar; Qing Cao; Alisa B Lee; Bruce R Blazar; David N Cornfield; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

2.  Antigen-mediated T cell expansion regulated by parallel pathways of death.

Authors:  Irene L Ch'en; Daniel R Beisner; Alexei Degterev; Candace Lynch; Junying Yuan; Alexander Hoffmann; Stephen M Hedrick
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

Review 3.  Imaging flow cytometry: coping with heterogeneity in biological systems.

Authors:  Natasha S Barteneva; Elizaveta Fasler-Kan; Ivan A Vorobjev
Journal:  J Histochem Cytochem       Date:  2012-06-27       Impact factor: 2.479

Review 4.  Functions of caspase 8: the identified and the mysterious.

Authors:  Guy S Salvesen; Craig M Walsh
Journal:  Semin Immunol       Date:  2014-05-21       Impact factor: 11.130

Review 5.  Programmed necrosis and autophagy in immune function.

Authors:  Jennifer V Lu; Craig M Walsh
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

6.  Enzymatically active single chain caspase-8 maintains T-cell survival during clonal expansion.

Authors:  S Leverrier; G S Salvesen; C M Walsh
Journal:  Cell Death Differ       Date:  2010-06-04       Impact factor: 15.828

7.  Caspase-8 restricts natural killer cell accumulation during MCMV Infection.

Authors:  Yanjun Feng; Lisa P Daley-Bauer; Linda Roback; Marc Potempa; Lewis L Lanier; Edward S Mocarski
Journal:  Med Microbiol Immunol       Date:  2019-05-21       Impact factor: 3.402

Review 8.  Caspase-8 as a therapeutic target in cancer.

Authors:  Dwayne G Stupack
Journal:  Cancer Lett       Date:  2010-09-03       Impact factor: 8.679

9.  Retinoic acid induces nuclear accumulation of Raf1 during differentiation of HL-60 cells.

Authors:  James Smith; Rodica P Bunaciu; Gudrun Reiterer; David Coder; Thaddeus George; Michael Asaly; Andrew Yen
Journal:  Exp Cell Res       Date:  2009-03-17       Impact factor: 3.905

Review 10.  MHC class II regulation by epigenetic agents and microRNAs.

Authors:  Thomas B Tomasi; William J Magner; Jennifer L Wiesen; Julian Z Oshlag; Felicia Cao; Alex N Pontikos; Christopher J Gregorie
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.